Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer

Modern Pathology

Volumn 26, Issue 2, 2013, Pages 295-301

  Karamitopoulou, Eva ^a,b   Zlobec, Inti ^a   Kölzer, Viktor ^a   Kondi Pafiti, Agathi ^b   Patsouris, Efstratios S ^b   Gennatas, Konstantin ^c   Lugli, Alessandro ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

colorectal cancer; prognosis; score; tumor budding

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR BUDDING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS;

EID: 84873405943     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.155     Document Type: Article

References (22)

1. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007;50:151-162.
2. Brabletz T, Jung A, Spaderna S, et al. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5: 744-749.
3. Zlobec I, Lugli A, Baker C, et al. Role of APAF-1, E-cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer. J Pathol 2007; 212:260-268.
4. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009;119: 1417-1419.
5. Compton C. Prognostic Factors in Cancer, 3rd edn. John Wiley & Sons, Inc.: New York, 2006.
6. Compton C. Pathology and prognostic determinants of colorectal cancer, In: Tanabe K, Savarese D(eds) UpToDate. Wolters Kluwer Health: Waltham, MA, 2012.
7. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor 'budding' in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-635.
8. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-132.
9. Ishikawa Y, Akishima-Fukasawa Y, Ito K, et al. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer 2008;112: 924-933.
10. Kazama S, Watanabe T, Ajioka Y, et al. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 2006;94:293-298.
11. Nakamura T, Mitomi H, Kikuchi S, et al. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology 2005;52: 1432-1435.
12. Ueno H, Mochizuki H, Hashiguchi Y, et al. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 2004;91:327-333.
13. Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;127:385-394.
14. Wang LM, Kevans D, Mulkahy H, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 2009;1:134-141.
15. Nakamura T, Mitomi H, Kanazawa H, et al. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis Colon Rectum 2008;51: 568-572.
16. Ueno H, Mochizuki H, Shinto E, et al. Histologic indices in biopsy specimens for estimating the probability of extended local spread in patients with rectal carcinoma. Cancer 2002;94:2882-2891.
17. Ueno H, Price AB, Wilkinson KH, et al. A new prognostic staging system for rectal cancer. Ann Surg 2004;240:832-839.
18. Koelzer V, Horcic M, Karamitopoulou E, et al. Tumour budding score based on 10 high-power fields (HPFs) is a reliable basis for a standardized scoring system in colorectal cancer (Abstract). Virchows Arch 2011; 459:S156.
19. Park KJ, Choi HJ, Roh MS, et al. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 2005;48: 1597-1602.
20. Prall F, Nizze H, Barten M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005;47:2005.
21. Zlobec I, Molinari F, Martin V, et al. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol 2010;16:4823-4831.
22. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005;97: 1180-1184.